Source: Hepatoma Research. Unidades: FMRP, FZEA
Subjects: HEPATITE, CIRROSE HEPÁTICA, CARCINOMA HEPATOCELULAR, APOPTOSE, NEOPLASIAS HEPÁTICAS
ABNT
DELLA PORTA, Lívia Maria et al. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatoma Research, v. 3, p. 34-42, 2017Tradução . . Disponível em: https://doi.org/10.20517/2394-5079.2016.39. Acesso em: 01 set. 2024.APA
Della Porta, L. M., Ramalho, F. S., Oliveira, C. A. F. de, Silva, D. M. da, Augusto, M. J., & Ramalho, L. N. Z. (2017). Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatoma Research, 3, 34-42. doi:10.20517/2394-5079.2016.39NLM
Della Porta LM, Ramalho FS, Oliveira CAF de, Silva DM da, Augusto MJ, Ramalho LNZ. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma [Internet]. Hepatoma Research. 2017 ; 3 34-42.[citado 2024 set. 01 ] Available from: https://doi.org/10.20517/2394-5079.2016.39Vancouver
Della Porta LM, Ramalho FS, Oliveira CAF de, Silva DM da, Augusto MJ, Ramalho LNZ. Comparison of p53 and prohibitin expression in the spectrum of hepatitis, cirrhosis, and hepatocellular carcinoma [Internet]. Hepatoma Research. 2017 ; 3 34-42.[citado 2024 set. 01 ] Available from: https://doi.org/10.20517/2394-5079.2016.39